Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early recombinant human brain natriuretic peptide in emergency acute left heart failure
ChiCTR-ONC-13003823Phase 4Completed
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nesiritide in acute left heart failure (ALHF) and heart failure (HF), sponsored by Beijing Chaoyang Hospital. Primary endpoints: NT-proBNP, Vital signs and 5 more. Started Sep 2011; status: completed.
02
Drugs
nesiritide
03
Conditions
acute left heart failure (ALHF)heart failure (HF)
Beyond the preview
Go deeper on ChiCTR-ONC-13003823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13003823.